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Complete congenital stationary night blindness (cCSNB) is associated with loss of function of rod and cone ON bipolar cells in the
mammalian retina. In humans,mutations inNYX andGRM6have been shown to cause the condition. Through the analysis of a consan-
guineous family and screening of nine additional pedigrees, we have identiﬁed three families with recessive mutations in the gene
TRPM1 encoding transient receptor potential cation channel, subfamily M, member 1, also known as melastatin. A number of other
variants of unknown signiﬁcance were found. All patients had myopia, reduced central vision, nystagmus, and electroretinographic
evidence of ON bipolar cell dysfunction. None had abnormalities of skin pigmentation, although other skin conditions were reported.
RNA derived from human retina and skin was analyzed and alternate 50 exons were determined. The most 50 exon is likely to harbor an
initiation codon, and the protein sequence is highly conserved across vertebrate species. These ﬁndings suggest an important role of this
speciﬁc cation channel for the normal function of ON bipolar cells in the human retina.Congenital stationary night blindness (CSNB) is a group of
genetically determined, nondegenerative disorders of the
retina associated with lifelong deﬁcient vision in the dark
andoftennystagmus andmyopia. Two common subgroups
have been characterized, despite an essentially normal
fundus appearance, on the basis of the electroretinographic
(ERG) and psychophysical ﬁndings:1 complete (cCSNB)
and incomplete (icCSNB). Both subtypes show a character-
istic ‘‘negative’’ ERG in response to a bright white ﬂash in
the dark-adapted eye, such that the b-wave is of lower
amplitude than a normal a-wave. The complete form shows
an undetectable rod-speciﬁc ERG to a dim light under dark
adaptation, characteristic changes in the standardphotopic
ERGs, and a characteristic loss of the ON b wave, derived
from rod and cone ON bipolar cells, with a normal OFF
response, derived from cone OFF bipolar cells, on long-
duration photopic stimulation.2 To date, mutations in
NYX (MIM *300278), on chromosome X,3 and GRM6
(MIM *604096), on chromosome 5,4 have been shown to
cause cCSNB. GRM6 encodes the metabotropic glutamate
receptor 6 (mGluR6) situated on the dendrites of rod and
cone ON bipolar cells.5 It mediates the sign inversion that
occurs at the ﬁrst synapse, such that glutamate release in
the dark by photoreceptors causes hyperpolarization of
the ON bipolar cell membrane.6 The function of the NYX
protein product remains unknown.7–10 The nature of the
channel or channels, as well as the components of the
signaling pathway, that respond to mGluR6 signaling in
ON bipolar cells also remains uncharacterized.11,12 GRM6
mutations have not been detected in all cases of auto-
somal-recessive cCSNB, suggesting that further autosomal
genes remain to be identiﬁed. Recently, reduced expressionThe Americanof the gene encoding transient receptor potential cation
channel, subfamily M, member 1 (TRPM1 [MIM *603576])
has been discovered in the skin and retina of horses homo-
zygous for the Appaloosa trait locus, characterised by night
blindness, a cCSNBphenotype on electroretinography, and
skin depigmentation,13 although the genomicDNAvariant
causing the reduced expression is yet to be determined.
Binding of the TRPM1 channel protein with nyctalopin
has recently been shown,14 and those ﬁndings suggest
this channel as a candidate for effecting the membrane
voltage change inONbipolar cells in response to glutamate.
Moreover, ON bipolar cell transduction currents recently
determined inmouse retina strongly suggest thata transient
receptor potential (TRP) channel mediates the light-
induced depolarization of this cell type.15
All patients involved in this study provided informed
consent as part of a research project approved by the local
research ethics committee, and all investigation was
conducted in accordancewith the principles of theDeclara-
tion of Helsinki. We investigated a consanguineous family
(family 1, Figure 1) of South Asian ethnicity, in which
the proband, V:1, a two-year-old girl, was diagnosed with
CSNB at 11 months of age. She was noticed to have
nystagmus and convergent squint at the age of 5 months.
There are multiple consanguineous marriages within the
family; hermother and amaternal uncle also had anonpro-
gressive night blindness. Cycloplegic refraction of the
proband at 13 months was14.00/1.003170 in the right
eye (OD) and13.00/1.00320 in the left eye (OS). Fundo-
scopy showed pale optic discs in both eyes and signs of
pallor of the fundal reﬂex, consistent with myopia. The
father and paternal grandmother had a normal ocular1University College London (UCL) Institute of Ophthalmology, London EC1V 9EL, UK; 2Moorﬁelds Eye Hospital, London EC1V 2PD, UK
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Figure 1. Pedigrees from Evaluated Families
Electropherograms of DNA sequence surrounding likely disease-causing variants are shown beneath each pedigree.examination. Her mother, 28 years old, presented with
nonprogressive nyctalopia from an early age, as well as
convergent squint. She had bilateral high myopia (23D
spherical equivalent in each eye). Corrected visual acuities
were 0.26 logMAR (logarithm of the minimal angle of
resolution) for the right and 0.32 logMAR for the left eye.
Fundus examination showed myopic fundi (Figure 2A).
A second daughter, who developed nystagmus within the
ﬁrst year of life, has not been examined formally. The
affected mother, elder daughter, and maternal uncle were
all said to have dry skin and required application of emol-
lients but no further dermatological treatments. Electro-
physiology was performed on the mother, and the results
are shown in the top trace of Figure 3. The features were
typical of cCSNB, suggesting ON- pathway dysfunction in
rods and all cone types.
DNA samples from the unaffected father and affected
mother of family 1 were genotyped for 58,614 SNPs with
the use of the Genechip Human Mapping 50k Xba Array
(Affymetrix, Santa Clara, CA, USA). Samples were prepared
with the use of the GeneChip Mapping 50K Xba Assay Kit712 The American Journal of Human Genetics 85, 711–719, Novemas recommended by the manufacturer (Affymetrix). All
chip data were imported into the Gene Chip Operating
Software (GCOS) platform, and genotype data were ex-
tracted with the Gtype 4.0 SNP calling algorithm (Affyme-
trix). The pedigree was consistent with the propagation of
a single mutant allele from a recent ancestor such that
the unaffected father was heterozygous and the affected
mother autozygous for this allele. A routine was written
in Visual Basic within the Microsoft Excel program (Micro-
soft, Redmond, WA, USA) for the detection of genomic
regions obeying this rule. The largest of four such regions,
each greater than 1 Mb, consisted of 15.9 Mb comprising
proximal chromosome 15q and included 280 contiguous
SNPs. It was ﬂanked by polymorphisms rs2090622 (prox-
imal 15q) and rs10518928 (Figure 4). On interrogation of
the Ensembl database, 106 distinct annotated Unigene
clusters fell within the region, and each was inspected for
its spectrum of tissue expression with the use of entries
in the human dbEST database. One obvious candidate
was a transient potential cation channel, subfamily M,
member 1 (TRPM1) expressed in eye and skin. Primersber 13, 2009
were designed for ampliﬁcation of the coding region
and intron-exon boundaries of the 27 published exons
(NM_002420.4) (Table S1, available online). Sanger
sequencing with the use of ﬂuorescently labeled di-deoxy-
nucleotides (Big-Dye Terminator v3.1) on the ABI3730
platform was undertaken on genomic DNA (Applied Bio-
systems, Forster City, CA, USA) extracted from blood leuko-
cytes of both parents. A homozygous variant was identiﬁed
in the second nucleotide of the intron 16 donor site in the
affected mother (IVS16þ2T>C). The father was heterozy-
gous for this variant. Such a base substitution would be
expected to abrogate the canonical donor sequence and
Figure 2. Color Fundus Photographs
(A) Color fundus photographs of patient
IV:3 in family 1.
(B) Color fundus photographs, fundus
autoﬂuorescence, and Goldmann kinetic
perimetry of patient II:2 in family 2. Gold-
mann perimetry isopters for targets III4a,
II4a, and I4a are shown.
to affect efﬁcient splicing of intron
16 of the gene. RNA was not available
for a test of this assertion.
Additional patients and families
with a phenotype consistent with
cCSNB, attending the retinal clinics
at Moorﬁelds Eye Hospital, were
screened for mutations in GRM6 and,
if male, NYX. We purposefully biased
the cohort toward female patients
and siblings, to enrich it for autosomal
genes. Of 12 families screened for
GRM6 mutations, three were found
to have mutations. Only one family
was consistent with X-linked segrega-
tion, and was therefore screened for
NYX, which also showed no muta-
tions. The nine familes that were
negative were screened for mutations
in TRPM1. Likely disease causing
alleles were detected in two additional
pedigrees (Figure 1, Table 1), both of
white European descent. Also found
were other variants whose patholog-
ical signiﬁcance was unclear, which
either failed to segregate with the
disorder or were found on only one
allele in an affected patient. All vari-
ants are listed in Table 1. The single
affected person in family 2, a 36-year-
old female, had onset of nystagmus
in the ﬁrst year of life and was
diagnosed with CSNB at the age of
16 years. She had a pituitary gland
enlargement without evidence of
suprasellar extension or pituitary hormone dysfunction.
She had received treatment for ‘‘eczema’’ in the past. Her
best-corrected visual acuities were 1.00 logMAR OD and
0.84 logMAR OS. She was myopic (15.50/1.50350 OD
and 14.50/1.00390 OS) and had normal color vision
and full visual ﬁelds on Goldmann kinetic perimetry. On
examination, she had right convergent squint and
pendular nystagmus, andmyopic changes were evident on
fundoscopy. Fundus autoﬂuorescence imaging, performed
with the Heidelberg Retinal Angiograph-II (Heidelberg
Engineering, Germany), was normal (Figure 2B). Electro-
physiology (second trace of Figure 3) was typical of cCSNB.The American Journal of Human Genetics 85, 711–719, November 13, 2009 713
Figure 3. International-Standard Full-Field ERGs and Pattern ERGs from One Eye of Three Affected Individuals and One Control
Subject
Top to bottom: patient IV:3 in family 1, patient II:2 in family 2, patient II:1 in family 3, control subject. Columns 1 and 2 show dark-
adapted ERGs for ﬂash intensities of 0.01 and 11.5 cd.s/m2 (columns 1 and 2). Columns 3 and 4 show light-adapted ERGs for a ﬂash
intensity of 3.0 cd.s/m2 presented at 30Hz (column 3) or 2Hz (column 4). Column 5 shows pattern ERGs (PERGs) recorded to an alter-
nating checkerboard (check size 0.75 degrees, 4 reversals per s). Column 6 shows additional ON-OFF ERGs that use an orange stimulus
(560 cd/m2, duration 200ms) superimposed on a green background (150 cd/m2). Column 7 shows S-cone ERGs that use a blue stimulus
(445 nm, 80 cd/m2) on an orange background (620 nm, 560 cd/m2). Dim-ﬂash rod ERGs are undetectable (column 1). Bright-ﬂash, dark-
adapted ERGs are profoundly electronegative, with a b-wave of much lower amplitude than the borderline orminimally reduced a-wave.
Photopic 30 Hz ﬂicker ERGs show a slightly ﬂattened trough and normal (patient II:1 in family 3) to marginally delayed peak times.
Photopic single-ﬂash ERGs show a broadened a-wave trough and a reduced-amplitude, sharply-rising b-wave lacking photopic oscilla-
tory potentials. PERGs are undetectable, in keeping with macular involvement. Photopic ON-OFF ERGs show a profoundly reduced ON
b-wave with relative sparing of the OFF response. S-cone ERGs show loss of the S-cone-speciﬁc component (the latter of the two peaks in
the control subject), with some reduction in the amplitude of the L-M cone peak (the earlier of the two peaks in the normal). The
ﬁndings therefore suggest ON pathway dysfunction in rods and all cone types.The unaffected mother underwent electrophysiology for
the determination of whether heterozygosity for TRPM1
mutation had a subclinical effect, and these results were
entirely normal. In family 3, two siblings were affected
with night blindness, and one, a 24-year-old female, was
examined. She had nystagmus and a left divergent squint
from birth and reported difﬁculties seeing at night and
poorer vision in her left eye from an early age. She had
been investigated for blistering of the skin andwas thought
to have an uncharacterized condition similar to epidermol-
ysis bullosa simplex. She took regular thyroxine for hypo-
thyroidism. Visual acuity at age 20 was 0.28 logMAR OD
and 1.00 logMAR OS (which is thought to be amblyopic).
She was myopic (4.25D in each eye) and had a left diver-
gent squint and nystagmus. Fundal examination showed
bilateral tilted optic discs but was otherwise unremarkable
Electrophysiology (third trace in Figure 3) was typical of
cCSNB.714 The American Journal of Human Genetics 85, 711–719, NovemThe affected proband of family 2 was found to have
two likely disease-causing mutations in the TRPM1 gene
(c.412delG [p.G138fs] and c.3105T>A [p.Y1035X]). Anal-
ysis of the mother showed that these variants were in
trans. Both cause a premature termination codon, which
would be predicted to cause the mRNA to succumb to
nonsense-mediated decay. The proband of family 3 was
found to harbor two missense variants not found in 192
unrelated individuals from the same ethnic group
(c.220C>T [p.R74C] and c.3004A>T [p.I1002F]). It has so
far not been possible to test segregation in other members
of the family, nor to obtain RNA from the proband for
ampliﬁcation for the examination of cloned fragments.
We cannot therefore be sure that these variants reside on
different chromosomes. We employed the Sorting Intol-
erant From Tolerant (SIFT) and Polymorphism Phenotyp-
ing (PolyPhen) algorithms to assess these and other
missense variants indentiﬁed in this study for likelyber 13, 2009
Figure 4. Region of Autozygosity Mapping and Analysis Of Gene Structure for the TRPM1 Gene
(A) Region of autozygosity for family 1 on chromosome 15q, of 15.9 Mb and 280 SNPs ﬂanked by rs2090622 and rs10518928. A total of
106 Unigene clusters were found in the region. Only the partial region is shown in this ﬁgure.
(B) Results of RACE experiments for TRPM1 transcripts in human retina and skin. One transcript with a 201 bp 50 extension of the
published exon 1 was found in both skin and retinal tissue. An alternative and previously unreported 50 exon of 275 bp, denoted
here as exon 1a, was detected in retina approximately 84 Kb upstream of the published exon 2, spliced directly to exon 2 (omitting
exon 1). Approximate physical distances are shown.
(C) The start codon of TRPM1 in the published sequence (NM_002420.4) is shown (rs4779816), with other likely translation start sites in
the different transcripts.pathogenicity, and the results are shown in Table 1. The
SIFT algorithm deploys sequence homology to calculate
a score, determining the evolutionary conservation status
of the amino acid of interest and predicting whether its
substitution will affect protein function. Substitutions at
speciﬁc positions showing normalized probabilities less
than the chosen cutoff value of 0.05 are predicted to be
deleterious, and those greater than or equal to 0.05 are pre-
dicted to be tolerated. The higher the tolerance index, the
less functional impact a particular amino acid substitution
is likely to have.16 Polyphen evaluates the location of the
substitution, the function of that region, and whether
the substitution is likely to affect the three-dimensional
structure of the protein. The prediction is based on the
position-speciﬁc independent counts (PSIC) score derived
from a composite of these calculations. PolyPhen scores
greater than 2.0 indicate probable damage to protein func-The Americation, scores of 1.5–2.0 indicate possible damage, and scores
of lower than 1.5 indicate benign.17 Results are summa-
rized in Table 1.
The published sequence (NM_002420.4) suggested
an initiation methionine codon within exon 2, which
was also listed as a single-nucleotide polymorphism
(rs4779816). We tested this variant in 192 anonymized
blood donors from the UK (European Collection of Cell
Cultures, ECACC, Salisbury, UK) and found a minor allele
prevalence of 0.199, which suggested strongly that another
position in the transcript was used for initiation of protein
translation. Thenext 30 ATGcodon in framewith thedown-
stream sequence was located in exon 3. To investigate the
full-length transcripts in human retina and skin RNA, we
performed 50 and 30 RACE (rapid ampliﬁcation of cDNA
ends) experiments (Figure 5 and Table S2). cDNA products
from the RACE reactions were analyzed on a 2% agarosen Journal of Human Genetics 85, 711–719, November 13, 2009 715
Table1. Summary of DNA Variants
DNA Variants SIFTa PolyPhen
Nucleotide Protein
Type of
Change Family No. Prediction
Tolerance
Index Predictionb
PSIC Score
Differencec Blosum62d
Frequency
in Controlse
IVS16þ2T>C splicing homozygous 1 N/A N/A N/A N/A N/A 0/384 chromosomes
c.412 delG p.G138fs heterozygous 2 N/A N/A N/A N/A N/A 0/384
c.3105T>A p.Y1035X heterozygous 2 N/A N/A N/A N/A 4 0/384
c.220C>T p.R74C heterozygous 3 intolerant 0 POD 2.495 3 0/384
c.3004A>T p.I1002F heterozygous 3 intolerant 0 POS 1.799 0 0/384
c.167A>G p.Y56C heterozygous f intolerant 0 POD 2.544 2 0/384
c.2162G>A p.R721Q heterozygous f intolerant 0.01 POS 1.754 1 0/384
c.2648A>G p.E883G heterozygous f intolerant 0 POD 2.284 2 0/384
c.2885A>C p.M962T heterozygous g intolerant 0 benign 0 1 0/384
c.4312A>G p.R1438G heterozygous g tolerant 0.07 POD 2.006 2 0/384
c.95G>A p.S32N tolerant 0.49 benign 1.333 1 rs2241493
c.1239G>A p.T413T tolerant 0.42 N/A N/A 5 rs1035705
c.1813G>A p.V605M tolerant 0.31 benign 1.289 1 rs17815774
c.2307T>C p.Y769Y tolerant 0.12 N/A N/A 7 rs12913672
c.2340T>C p.N780N tolerant 0.18 N/A N/A 6 rs2288242
c.4182G>A p.V1395I tolerant 0.34 benign 0.127 3 rs3784588
c.2T>C p.M1T intolerant 0.43 benign 0 1 rs4779816–minor allele
frequency 76/384
c.16C>T p.R6W h intolerant 0 POS 1.8 3 6/32 chromosomes
IVS14-64A>C N/A N/A N/A N/A N/A rs12907509
IVS17þ82G>T N/A N/A N/A N/A N/A rs12708421
IVS23-24G>C N/A N/A N/A N/A N/A C allele in 8/28
chromosomes
Unless otherwise specified, variant numbering is based on NM_002420.4
a SIFT: Sorting Intolerant from Tolerant16—range 0–1, a lower score indicating intolerance to the substitution.
b POD: probably damaging; POS: possibly damaging.
c PSIC: Position-Specific Independent Counts. A high difference (range 0–4) indicates intolerance to the substitution.17
d Blosum62: BLOcks of Amino Acid SUbstitution Matrix.26 Positive numbers indicate a substitution more likely to be tolerated evolutionarily, negative numbers
indicate the opposite.
e Controls were anonymized UK blood donors (ECACC). Unless otherwise specified, 192 samples were used.
f Each were found in a simplex patient with cCSNB, in whom no other mutation was detected.
g These two variants were found in cis, in a single female simplex patient. No other mutations were detected. Although the ERG showed a typical cCSNB pheno-
type, the night blindness was not congenital, having started in the third decade. A different molecular pathology is likely.
h Numbering is based on TRPM1 exon 1a (see main text), registered as ss161641214 with dbSNP.gel and generated two distinct bands of approximately
500 bp and 200 bp. Bands were excised, subcloned into
pCR4-TOPO vector (Invitrogen, Carlsbad, CA, USA), and
sequenced in both directions. Clones derived from the
200 bp fragment included the published exon 1 sequence.
Clones derived from the 500 bp fragments included a
201 bp 50 extension of the currently published exon 1 of
TRPM1 (Figure 4). This sequence did not extend the reading
frame of the gene and contained three stop codons. Hence,
this 50 extension did not generate an alternative ATG start
codon in frame with the downstream sequence. Secondly,716 The American Journal of Human Genetics 85, 711–719, Novema previously uncharacterized sequence at the 50 end of
some transcripts was found in a proportion of retinal clones
with a similar molecular weight. Sequence analysis showed
a 275-bp-long 50 fragment contiguous with the sequence of
exon 2 containing a 30 extension of the open reading frame
(Figure 4, accession number: GQ502181); with the use of
the BLAT program, this exonic sequence was found to be
situated approximately 84 Kbp upstream of exon 2 in the
published human genomic DNA sequence. The published
exon 1 was absent from these clones. ClustalW analysis of
the TRPM1 homologs from diverse vertebrate genomesber 13, 2009
Figure 5. Experiments Examining
TRPM1 RNA and 50 RACE Experiments
(A) The integrity of RNA samples from
human retina and skin were assessed with
the Experion system (Bio-Rad, Hercules,
CA, USA). The traces show similar peaks
and ratios for 28S and 18S RNA molecules
(vertical axis, ﬂuorescence intensity; hori-
zontal axis, migration time), suggesting
low degradation and comparable quality
from both tissues. The right panel shows
thedata as a computer-generatedgel image.
(B) 2%agarose gel of DNA fragments gener-
ated from 50 RACE experiments from the
RNA assessed in Figure 5A (see main text
and Table S2). With the use of a primer
complimentary to a 50 adapter oligonucleo-
tide (Invitrogen, Carlsbad, CA, USA) and
a gene-speciﬁc primer complimentary to
exon 3, two main bands were produced,
consistent with the published sequence
(smaller band, 200 bp), as well as a mixture
of the previously unreported 50 exon 1a
(~475 bp) and as the 5’ extension of exon
1 (475 bp), also previously unreported.
The larger band was predominant in the
retina, and the smaller was predominant
in skin.
(C) After the generation of sequence from
multiple clones of the 50 RACE products (see main text), RT-PCR experiments were performed on skin and retina RNA and separated on
2% agarose, with the use of primers shown in the schematic below for determination of the presence of the various transcripts in the
two tissues. The skin consistently failed to amplify for two different primers in exon 1a when used with reverse primers from exon 3
and 6. RT-PCR from comparable amounts of RNA gave less-dense bands than that in the retina for all other primer combinations. Lanes
indicate the following: lane 0, ladder (subsequent lanes are paired reactions from retina and skin); lanes 1 and 2, 1aF and 3R; lanes 3 and 4,
1aF1 and 6R; lanes 5 and 6, 1F1 and 3R; lanes 7 and 8, 1F2 and 3R; lanes 9 and 10, 1F1 and 6R; lane 11, PCRwith 1F1 and 6R fromgenomic
DNA control; lane 12, same as 11 with water as control.showed that this 50 exon (hitherto referred to as exon 1a)
was highly conserved (Figure S2). For conﬁrmation of the
presence of this splice variant, RT-PCR experiments were
performedwith the use of a forward primer complimentary
to the 50 end of exon 1a and two reverse primers from the
sequence of TRPM1 exon 3–4 junction and exon 6. PCR
products were readily visualized from the retinal tissue but
were not found in same experiments for the skin tissue.
Moreover, a band of the expected size was generated with
the use of a 30 primer complimentary to exon 27, conﬁrm-
ing the presence of this exon 1a within the full-length
transcript in human retina (~4500 bp, data not shown).
Additional RT-PCR experiments were performed with the
50 primers with those complimentary to 30 exons, in both
skin and retinal RNA, and these experiments are summa-
rized in Figure 5. Hence, it is likely that, at least in retina,
the protein is longer at the amino end than is as yet appre-
ciated. For the 30 RACE experiment, it wasmandatory to use
an Oligo dT primer (GeneRacer Kit, Invitrogen) with a 24
nucleotide tail because a shorter primer appeared to bind
internally to poly-A sequences. The resulting sequence
analysis showed 30-untranslated region sequences in both
retina and skin that were identical to the published
TRPM1 30 sequence. The sequences found in this study
were sequenced in all probands, and a common coding
SNP was identiﬁed: p.R6W (dbSNP ss161641214, Table 1),
but no further variants were found.The AmericanTheﬁnding of likely disease-causingmutations inTRPM1
in patientswith electroretinographic evidence of loss ofON
bipolar cell function (Figure 3), qualitatively identical to
that seen in patients reported with GRM6 mutation,4
suggests an important role of this cation channel in the
normal function of ON bipolar cells in the human retina.
Transient receptor potential (TRP) channels are a family
of membrane protein channels permeable to cations, with
diverse functions. The ﬁrst member of the family to be
described followed the discovery of a mutant of Drosophila
melanogaster with photoreceptor degeneration,18 and a
mammalian homolog exists as TRPC1.19 To date, 28
mammalian TRP channels have been identiﬁed and can
be divided into six subfamilies: TRPC, TRPV, TRPM, TRPP,
TRPML, and TRPA.20–23 In the TRPM subfamily, TRPM1,
the founding member was identiﬁed as an RNA sequence
in a mouse melanoma cell line and was subsequently
noticed to be expressed in melanomas with lower meta-
static potential; the protein was subsequently termed
melastatin.24 In the same year, Hunter et al. cloned a long
transcript variant cDNA from a human retina cDNA
library.25 Recently, TRPM1has been described as the poten-
tial cause of CSNB and coat-spotting pattern in the Appa-
loosa horse.13 It is unclear whether the affected patients
of the three families described here have skin manifesta-
tions of TRPM1 mutation. None had any suggestion of
pigment disturbance such as that reported in theAppaloosaJournal of Human Genetics 85, 711–719, November 13, 2009 717
horse, each having a normal distribution of pigment in
skin and hair and a tanning response no different to that
of unaffected relatives. All probands reported dry or scaly
skin, and one, the proband of family 3, required manage-
ment by a specialist. Further clinical investigation is
required if we are to know whether this represents a mani-
festation of TRPM1 dysfunction or absence in human skin.
Also, a rare disorder, melanoma-associated retinopathy, is
an accurate retinal phenocopy for the disorder described
here andmight suggest that an epitope ofmelastatin causes
autoimmune targeting of retinal ON bipolar cells.
Intriguingly, in our cohort, there remained a handful of
families with a cCSNB phenotype without mutations in
NYX, GRM6, or TRPM1, suggesting that there may be addi-
tional genes that cause this disorder. The identiﬁcation
of such genes will provide further insights into the ON
bipolar cell’s signaling-pathway components that link
the activation of metabotropic glutamate channels with
the permeability state of TRPM1 membrane channels.
Supplemental Data
Supplemental Data include two ﬁgures and two tables and can be
found with this article online at http://www.cell.com/AJHG.
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Web Resources
The URLs for data presented herein are as follows:
An Organized View of the Transcriptome (Unigene), http://www.
ncbi.nlm.nih.gov/sites/entrez?db¼unigene
BLAST like Alignment tool (BLAT), http://genome.ucsc.edu/
cgi-bin/hgBlat?command¼start
Ensembl, http://www.ensembl.org/index.html
Expressed Sequence Tags database (dbEST), http://www.ncbi.nlm.
nih.gov/dbEST/
Multiple sequence alignment program for DNA or proteins
(ClustalW), http://www.ebi.ac.uk/Tools/clustalw2/index.html
NCBI SNP database (dbSNP), http://www.ncbi.nlm.nih.gov/
projects/SNP/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/omim718 The American Journal of Human Genetics 85, 711–719, NovembPolymorphism Phenotyping (PolyPhen), http://genetics.bwh.
harvard.edu/pph/index.html
Sorting Intolerant from Tolerant (SIFT), http://sift.jcvi.org/
Splice Site Prediction by Neural Network, http://www.fruitﬂy.org/
seq_tools/splice.html
UCSC Genomic Bioinformatics, http://genome.ucsc.edu/
index.html
Accession Numbers
The Genbank accession number for the TRPM1 exon 1a sequence
reported in this paper is GQ502181.
The dbSNP database accession number for the SNP in exon 1a
reported in this paper is ss161641214.
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